Crossmark

Evaluation of novel<i>N</i>′-(3-hydroxybenzoyl)-2-oxo-2<i>H</i>-chromene-3-carbohydrazide derivatives as potential HIV-1 integrase inhibitors

Crossref DOI link: https://doi.org/10.1039/C8MD00328A

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Jesumoroti, Omobolanle J. https://orcid.org/0000-0001-6152-9467
Faridoon, Faridoon https://orcid.org/0000-0002-9460-4352
Mnkandhla, Dumisani https://orcid.org/0000-0001-6874-3677
Isaacs, Michelle

Hoppe, Heinrich C. https://orcid.org/0000-0003-4409-1955
Klein, Rosalyn https://orcid.org/0000-0002-9859-3507
Funding

Funding for this research was provided by:

South African Medical Research Council (Flagship)

Organization for Women in Science for the Developing World
License Information

Accepted Manuscript valid from 2019-12-10
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Omobolanle J. Jesumoroti (ORCID)

: Faridoon (ORCID)

: Dumisani Mnkandhla (ORCID)

: Heinrich C. Hoppe (ORCID)

: Rosalyn Klein (ORCID)

: Rosalyn Klein (ResearcherID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 3 July 2018; Accepted 1 November 2018; Advance Article published 10 December 2018; Version of Record published 23 January 2019